Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis

Discovery and Optimization of a Novel Series of Dyrk1B Kinase Inhibitors To Explore a MEK Resistance Hypothesis Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A (DYRK1A) Inhibitors as Potential Therapeutics Comparative Efficacy and Selectivity of Pharmacological Inhibitors of DYRK and CLK Protein Kinases Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: Development of chemical probe ML315 DYRK1A inhibitors for disease therapy: Current status and perspectives Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors Discovery of DB18, a potent inhibitor of CLK kinases with a high selectivity against DYRK1A kinase Discovery and Characterization of Selective and Ligand-Efficient DYRK Inhibitors Novel Scaffolds for Dual Specificity Tyrosine-Phosphorylation-Regulated Kinase (DYRK1A) Inhibitors Structural Optimization and Pharmacological Evaluation of Inhibitors Targeting Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases (DYRK) and CDC-like kinases (CLK) in Glioblastoma